about
Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain).Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screeningSocial inequalities in a population based colorectal cancer screening programme in the Basque Country.Population-based colorectal cancer screening: comparison of two fecal occult blood testTrends in the prevalences of congenital anomalies and age at motherhood in a Southern European region: a population-based study.Effect of oral anticoagulants on the outcome of faecal immunochemical test.Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model.Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines.Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening.Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening.[Lesions detected in a colorectal cancer screening program in the Basque Country: first round (2009-2011)].Characteristics and Progression of Preclinical Inflammatory Bowel Disease.Factors influencing participation in colorectal cancer screening programs in Spain.Colorectal cancer in a second round after a negative faecal immunochemical test.Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests.[The Alliance for the Prevention of Colorectal Cancer in Spain. A civil commitment to society].Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model.Factors related to the participation and detection of lesions in colorectal cancer screening programme-based faecal immunochemical testRisk factors for severe complications of colonoscopy in screening programsThe consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysisCharacteristics of adenomas detected by fecal immunochemical test in colorectal cancer screeningScreening colonoscopy and risk of adverse events among individuals undergoing fecal immunochemical testing in a population-based program: A nested case-control studyQuality indicators and patient satisfaction in colonoscopyComment on Cobo-Cuenca, A.I.; Laredo-Aguilera, J.A.; Rodríguez-Borrego, M.-A.; Santacruz-Salas, E.; Carmona-Torres, J.M. Temporal Trends in Fecal Occult Blood Test: Associated Factors (2009-2017). Int. J. Environ. Res. Public Health 2019, 16, 2120
P50
Q33599540-CF1DAF32-87F7-4A40-A521-0566AA8762A5Q34576842-A91C193B-53E3-4E89-84E8-AFC9D16230D6Q35800004-E21F7A27-6483-4A10-9A4D-B85A1E906851Q37459521-5B64E086-ED7B-49E1-9AC0-5DADDB325E55Q37628584-AAA15241-DC3A-4FA6-AD8A-282470AF633BQ37632165-20B84F83-F0DF-42D8-AAD7-386F6E3182E2Q38648431-71AE1B33-84CD-427A-AC18-1199C5166024Q40638799-7F631C3F-0BB0-4D93-A453-9A8F126AB01CQ40875173-B345BC0E-9A21-4E65-9CF0-38C221C67A40Q41557427-7217A415-B255-4BD6-B604-952BBAEAFBA5Q44189797-036FE0BF-2DEB-41D6-9481-4D7C2D02E372Q45099887-0764AC79-715B-45B1-B125-49F3149C2E1BQ47605008-4398370A-E9B2-4427-AD62-EA179F475188Q48666228-183D1B06-6FFF-45B9-A0C2-B47BF8E51EF6Q50448499-4BEA9AD3-3583-4364-9820-DF7B77ED2D20Q50475473-20D776FA-57D7-47DB-B0E9-16EA150CA2DAQ51180109-AA60FC2B-E34F-4E66-8EF7-D877AB836BEAQ55220554-EB3888C7-4391-4756-A596-0F8337D10088Q58221548-485BA815-B52E-4396-8277-F00040FFA51FQ58588708-7C673E29-3394-4772-AD94-59797A42F4C1Q64075665-8B5AE28D-5DF8-4536-8E5A-522755B8786EQ88150206-7E5FE584-0F45-4450-883F-C33A02F4EB6AQ90791481-AB99EEF0-CB7B-4C87-B53A-0FCE016020C3Q91252709-6162756F-2F90-4EA5-AB01-C9D640F31DE7Q91962971-04B9102A-EEDE-4643-A962-A0BAF3B10DD4
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Isabel Portillo
@ast
Isabel Portillo
@en
Isabel Portillo
@es
Isabel Portillo
@nl
type
label
Isabel Portillo
@ast
Isabel Portillo
@en
Isabel Portillo
@es
Isabel Portillo
@nl
prefLabel
Isabel Portillo
@ast
Isabel Portillo
@en
Isabel Portillo
@es
Isabel Portillo
@nl
P106
P21
P31
P496
0000-0002-3871-3423